approval
saveTIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
April 18, 2024updated 5mo ago
community read0 votes
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalTRIUMEQ (ABACAVIR SULFATE) — FDA approvalApr 18, 2024
- approvalTIVICAY PD (DOLUTEGRAVIR SODIUM) — FDA approvalApr 18, 2024
- approvalTRIUMEQ PD (ABACAVIR SULFATE) — FDA approvalApr 18, 2024
- approvalJULUCA (DOLUTEGRAVIR SODIUM) — FDA approvalApr 18, 2024
- approvalDOVATO (DOLUTEGRAVIR SODIUM) — FDA approvalApr 18, 2024
- approvalDOVATO (DOLUTEGRAVIR SODIUM) — FDA approvalApr 5, 2024
comments(0)
5-min edit window · permanent after that